Press / Medias

Christensenella: the key to unlocking gut microbiome-based drug discovery?

Jan 2, 2019

Cornell patent deal helps LNC ramp-up microbiome therapeutics strategy

Dec 17, 2018

A Bordeaux, LNC Therapeutics veut développer l’arme absolue contre l’obésité

Oct 26, 2018

LNC Therapeutics Acquires Exclusive License for the Christensenella Patent from Cornell University

Oct 17, 2018

LNC Therapeutics lance son nouvel essai clinique, OBEMINALE 2, et traite son premier patient

Oct 10, 2018

European biotech companies enter IPO prep course

Sep 21, 2018